Sargramostim for Myeloid Dendritic Cell Deficiency
NCT01871467
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
2
Enrollment
OTHER
Sponsor class
Conditions
Dendritic Cell Deficiency
Interventions
DRUG:
Sargramostim
Sponsor
Johns Hopkins University